Patent · US Active

Oxaborole esters and uses thereof

US10882872B2 · kind B2 · utility

0Cited by
4References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 24, 2019
Grant dateJan 5, 2021
Priority date
Expiry dateSep 24, 2039

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides oxaborole ester compounds and compositions thereof which are useful to treat diseases associated with parasites, such as Chagas Disease and African Animal Trypanosomosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.